GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heron Therapeutics Inc (STU:AXD2) » Definitions » Accumulated other comprehensive income (loss)

Heron Therapeutics (STU:AXD2) Accumulated other comprehensive income (loss) : €-0.0 Mil (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Heron Therapeutics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Heron Therapeutics's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was €-0.0 Mil.

Heron Therapeutics's quarterly Accumulated other comprehensive income (loss) increased from Sep. 2023 (€-0.0 Mil) to Dec. 2023 (€0.0 Mil) but then declined from Dec. 2023 (€0.0 Mil) to Mar. 2024 (€-0.0 Mil).

Heron Therapeutics's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (€-0.0 Mil) to Dec. 2022 (€-0.0 Mil) but then increased from Dec. 2022 (€-0.0 Mil) to Dec. 2023 (€0.0 Mil).

Heron Therapeutics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Heron Therapeutics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heron Therapeutics Accumulated other comprehensive income (loss) Chart

Heron Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.21 -0.01 -0.02 0.01

Heron Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 -0.01 - 0.01 -0.01

Heron Therapeutics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Heron Therapeutics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Heron Therapeutics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Heron Therapeutics (STU:AXD2) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heron Therapeutics Inc (STU:AXD2) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
ALT OABI TRDA ALLO LXEO CABA ADPT OLMA NWBO YMAB OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
HRTX:USA AXD2:Germany
Address
4242 Campus Point Court, Suite 200, San Diego, CA, USA, 92121
Website
https://www.herontx.com
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011.

Heron Therapeutics (STU:AXD2) Headlines

No Headlines